← Back to Screener
eXoZymes Inc. Common Stock (EXOZ)
Price$10.50
Favorite Metrics
Price vs S&P 500 (26W)-29.23%
Price vs S&P 500 (4W)46.21%
Market Capitalization$91.91M
All Metrics
Book Value / Share (Quarterly)$0.40
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.79
Price vs S&P 500 (YTD)-2.33%
EPS (TTM)$-1.09
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-1.09
EPS (Annual)$-1.09
ROI (Annual)-261.23%
Cash / Share (Quarterly)$0.36
ROA (Last FY)-153.37%
EBITD / Share (TTM)$-1.11
Cash Flow / Share (Annual)$-0.79
P/B Ratio27.05x
P/B Ratio (Quarterly)26.91x
Net Income / Employee (Annual)$-0
ROA (TTM)-104.99%
EPS Incl Extra (Annual)$-1.09
Current Ratio (Annual)2.51x
Quick Ratio (Quarterly)2.27x
3-Month Avg Trading Volume0.00M
Revenue / Employee (TTM)$0
52-Week High$18.40
EPS Excl Extra (Annual)$-1.09
26-Week Price Return-25.24%
Quick Ratio (Annual)2.27x
13-Week Price Return11.98%
Total Debt / Equity (Annual)0.03x
Current Ratio (Quarterly)2.51x
Enterprise Value$88.982
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.36
3-Month Return Std Dev69.05%
Net Income / Employee (TTM)$-0
ROE (Last FY)-269.59%
EPS Basic Excl Extra (Annual)$-1.09
Total Debt / Equity (Quarterly)0.03x
EPS Incl Extra (TTM)$-1.09
ROI (TTM)-145.11%
Revenue / Share (Annual)$0.00
Year-to-Date Return-0.55%
5-Day Price Return-4.91%
EPS Normalized (Annual)$-1.09
ROA (5Y Avg)-71.83%
Month-to-Date Return44.34%
EBITD / Share (Annual)$-1.11
EPS Basic Excl Extra (TTM)$-1.09
P/B Ratio (Annual)26.91x
Book Value / Share (Annual)$0.40
Price vs S&P 500 (13W)11.30%
Beta1.62x
Revenue / Share (TTM)$0.00
ROE (TTM)-147.19%
52-Week Low$7.08
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
EXOZeXoZymes Inc. Common Stock | — | — | — | — | $10.50 |
AMGNAmgen Inc | 5.13x | 9.95% | 73.30% | 2.93% | $349.39 |
GILDGilead Sciences Inc | 5.84x | 2.40% | 78.83% | 133.64% | $138.55 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $828.35 |
BNTXBioNTech SE American Depositary Share | 8.75x | -11.81% | 84.21% | — | $102.12 |
BIIBBiogen Inc. Common Stock | 2.60x | 2.22% | 75.69% | -18.77% | $176.02 |
MRNAModerna, Inc. Common Stock | 11.02x | -39.93% | 70.32% | — | $54.68 |
NBIXNeurocrine Biosciences Inc | 4.49x | 21.45% | 98.18% | 2.31% | $128.41 |
EXELExelixis Inc | 4.96x | 6.85% | 96.39% | 31.10% | $44.38 |
TECHBio-Techne Corp. | 7.60x | 1.64% | 66.60% | -20.58% | $57.36 |
HALOHalozyme Therapeutics, Inc. | 5.74x | 37.55% | 83.62% | 22.89% | $66.64 |
About
EXoZymes develops a biomanufacturing platform for sustainable production of high-value biochemicals, including active pharmaceutical ingredients, biofuels, food flavors, and cosmetics. The company's platform offers a cost-effective alternative to traditional chemical synthesis across multiple end markets.